恶唑啉是一种含氧原子和氮原子的五元杂环化合物。它可能最早合成于1884年,但直到5年后,西格蒙·加布里埃尔才正确地指定了这种结构。它与Hantzsch–Widman命名法一致,是一族杂环化合物的一部分,在饱和度方面它存在于噁唑和噁唑烷之间。
-
4,4',5,5'-Tetrahydro-2,2'-bioxazole
2,2-双(2-噁唑啉)
-
BJS404669936697-72-097%
-
¥1077.005g
-
2,6-Bis((S)-4-isopropyl-4,5-dihydrooxazol-2-yl)pyridine
2,6-二[(4S)-4-异丙基-2-噁唑啉基]吡啶
-
BJS3893557118949-61-498% 99%ee
-
¥323.001g
-
(S)-4-tert-Butyl-2-(2-pyridyl)oxazoline
(S)-4-叔丁基-2-(2-吡啶基)恶唑啉
-
BJS5683540117408-98-798% 99%ee
-
¥365.001g
-
1,3-Bis((S)-4-((S)-sec-butyl)-4,5-dihydrooxazol-2-yl)benzene
1,3-双((S)-4-((S)-仲丁基)-4,5-二氢恶唑-2-基)苯
-
BJS7221695131380-86-498%
-
¥10599.001g
-
(S)-4-Isopropyl-2-(5-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole
(S)-4-异丙基-2-(5-(三氟甲基)吡啶-2-基)-4,5-二氢噁唑
-
BJS93679241803416-30-998%
-
¥311.00100mg
-
(3aR,8aS)-2-(4-(Trifluoromethyl)pyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole
(3aR,8aS)-2-(4-(三氟甲基)吡啶-2-基)-3a,8a-二氢-8H-茚并[1,2-d]噁唑
-
BJS33359822126903-00-097% 99%ee
-
¥1577.00250mg
-
(R)-2-(6-Benzhydrylpyridin-2-yl)-4-(tert-butyl)-4,5-dihydrooxazole
(R)-2-(6-二苯甲基吡啶-2-基)-4-(叔丁基)-4,5-二氢恶唑
-
BJS45469262757083-50-297% 99%ee
-
¥2224.00100mg
-
(4S,4'S)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4-isopropyl-4,5-dihydrooxazole)
(4S,4'S)-2,2'-(1-苯基丙烷-2,2-二基)双(4-异丙基-4,5-二氢恶唑)
-
BJS9325553698350-53-797%
-
¥466.00100mg
-
(S)-4-Benzyl-2-(4-methoxy-6-methylpyridin-2-yl)-4,5-dihydrooxazole
(S)-4-苄基-2-(4-甲氧基-6-甲基吡啶-2-基)-4,5-二氢噁唑
-
BJS08828642757082-40-798%
-
¥498.00100mg
-
(4S)-4-(sec-Butyl)-2-(pyridin-2-yl)-4,5-dihydrooxazole
(4S)-4-(仲丁基)-2-(吡啶-2-基)-4,5-二氢恶唑
-
BJS73091451620588-66-098%
-
¥806.00100mg
-
(4S,4'S)-2,2'-(2-(4-(tert-Butyl)phenyl)ethane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole)
(4S,4'S)-2,2'-(2-(4-(叔丁基)苯基)乙烷-1,1-二基)双(4-(叔丁基)-4,5-二氢恶唑)
-
BJS64288862634687-80-098%
-
¥542.00100mg
-
2,2-Bis((R)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)acetonitrile
2,2-双((R)-4-(叔丁基)-4,5-二氢恶唑-2-基)乙腈
-
BJS18389611442644-13-497%
-
¥3669.00250mg
-
(4R,5S)-2-(6-Methylpyridin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole
(4R,5S)-2-(6-甲基吡啶-2-基)-4,5-二苯基-4,5-二氢恶唑
-
BJS18306532417321-37-897% 99%ee
-
¥2161.00100mg
-
(R)-2-(5-Chloropyridin-2-yl)-4-isopropyl-4,5-dihydrooxazole
(R)-2-(5-氯吡啶-2-基)-4-异丙基-4,5-二氢恶唑
-
BJS32668582757083-23-997% 99%ee
-
¥9635.001g
-
(R)-4-Benzyl-2-(5-bromopyridin-2-yl)-4,5-dihydrooxazole
(R)-4-苄基-2-(5-溴吡啶-2-基)-4,5-二氢恶唑
-
BJS94634802757083-32-097% 99%ee
-
¥3335.00250mg
-
2-(Pyridin-2-ylmethyl)-4,5-dihydrooxazole
2-(吡啶-2-基甲基)-4,5-二氢恶唑
-
BJS76920172757085-39-397%
-
¥2029.00100mg
-
7-Bromo-2-methyl-2,3-dihydropyrazolo[5,1-b]oxazole
7-溴-2-甲基-2,3-二氢吡唑并[5,1-b]恶唑
-
BJS05199822676861-81-597%
-
¥16170.001g
-
(S)-2-(Benzo[b]thiophen-2-yl)-4-ethyl-4,5-dihydrooxazole
(S)-2-(苯并[b]噻吩-2-基)-4-乙基-4,5-二氢恶唑
-
BJS24369622828438-80-697%
-
¥1178.00100mg
-
(R)-2-(Benzo[b]thiophen-2-yl)-4-ethyl-4,5-dihydrooxazole
(R)-2-(苯并[b]噻吩-2-基)-4-乙基-4,5-二氢恶唑
-
BJS14135112828438-81-797%
-
¥1178.00100mg
-
(S)-2-(Benzo[b]thiophen-2-yl)-4-methyl-4,5-dihydrooxazole
(S)-2-(苯并[b]噻吩-2-基)-4-甲基-4,5-二氢恶唑
-
BJS37057122828439-74-198%
-
¥956.00100mg